Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
| Year |
Award Type |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
|---|---|---|---|---|---|---|---|
| 2005 | R21 | CA112228 | RFA-CA-05-002 | MURPHY, JOHN R. | BOSTON MEDICAL CENTER | NOVEL TARGETED REAGENTS THAT MODIFY ONCOGENE EXPRESSION | Complete |
| 2015 | R21 | CA191186 | RFA-CA-14-003 | BAILEY, RYAN C | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN | DROPLET MICROFLUIDIC PLATFORM FOR ULTRALOW INPUT EPIGENETICS | Complete |
| 2021 | R21 | CA236686 | CA20-017 | FARIS, GREGORY W | NUMENTUS TECHNOLOGIES INC. | Decoding Individual Exosomes in Cancer | Complete |
| 1999 | R21 | CA081721 | PAR-98-067 | BENSIMON, AARON | PASTEUR INSTITUTE | DETECTION OF GENOMIC ALTERATIONS BY MOLECULAR COMBING | Complete |
| 2007 | R21 | CA125285 | RFA-CA-07-002 | SHEA, LONNIE D | NORTHWESTERN UNIVERSITY | TRANSFECTED CELL ARRAYS FOR CANCER RESEARCH | Complete |
| 2017 | R21 | CA212500 | RFA-CA-16-001 | MOHS, AARON M. | UNIVERSITY OF NEBRASKA MEDICAL CENTER | Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications | NCE |
| 2020 | R21 | CA225493 | RFA-CA-19-019 | TEWARI, MUNEESH | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers | Active |
| 2009 | R21 | CA140068 | RFA-CA-08-006 | SHAPIRO, BENJAMIN | UNIV OF MARYLAND, COLLEGE PARK | SPATIAL, HIGH-ACCURACY, MULTIPLEXED MAPPING OF GENES IN HUMAN TISSUE SECTIONS | Complete |
| 2013 | R21 | CA173279 | RFA-CA-12-002 | SOPER, STEVEN ALLAN | UNIV OF NORTH CAROLINA CHAPEL HILL | ACUTE MYELOID LEUKEMIA: MRD ANALYSIS USING MODULAR UFLUIDICS AND UFLOW CYTOMETRY | Complete |
| 2019 | R21 | CA236652 | RFA-CA-18-004 | SINGAMANENI, SRIKANTH | WASHINGTON UNIVERSITY | METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION | Active |
| 2000 | R21 | CA086340 | PAR-99-102 | SMITH, RICHARD D | BATTELLE PACIFIC NORTHWEST LABORATORIES | HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER | Complete |
| 2022 | R21 | CA272345 | CA21-003 | KNOWLES, DAVID ARTHUR | NEW YORK GENOME CENTER | A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer | Active |
| 2002 | R21 | CA094334 | PAR-01-104 | SOMMER, STEVE SEEV | CITY OF HOPE/BECKMAN RESEARCH INSTITUTE | PAP: A TECHNOLOGY PLATFORM | Complete |
| 2005 | R21 | CA113917 | RFA-CA-05-002 | WANG, BINGHE | GEORGIA STATE UNIVERSITY | FLUORESCENT APTAMERS FOR GLYCOPROTEIN DETECTION | Complete |
| 2008 | R21 | CA125698 | RFA-CA-07-022 | LIOTTA, LANCE ALLEN | GEORGE MASON UNIVERSITY | SURROGATE AND SENTINAL TECHNOLOGIES TO MONITOR STABILITY OF CANCER PHOSPHOPROTEIN | Complete |
| 2015 | R21 | CA191239 | RFA-CA-14-003 | ELLINGTON, ANDREW D | UNIVERSITY OF TEXAS, AUSTIN | HIGH THROUGHPUT SINGLE CELL TRANSCRIPTOME ANALYSIS | Complete |
| 2021 | R21 | CA255979 | CA20-017 | DIDENKO, VLADIMIR V | BAYLOR COLLEGE OF MEDICINE | In situ assay imaging nuclear RNA exosome activity for cancer studies | Complete |
| 1999 | R21 | CA083231 | PAR-98-067 | WANG, YUE | CATHOLIC UNIVERSITY OF AMERICA | INTELLIGENT MAPPING OF GENE EXPRESSION PROFILES | Complete |
| 2007 | R21 | CA122904 | RFA-CA-07-002 | YEE, CASSIAN | FRED HUTCHINSON CAN RES CTR | IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CANCER | Complete |
| 2010 | R21 | CA138397 | RFA-CA-09-004 | WILLEY, JAMES C. | UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS | IMPLEMENTATION OF INNOVATIVE RNA SAMPLE QUALITY CONTROL METHODS | Complete |
| 2017 | R21 | CA212718 | RFA-CA-16-001 | VAN DAM, ROBERT MICHAEL | UNIVERSITY OF CALIFORNIA LOS ANGELES | High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer | Complete |